• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自噬菌体展示文库的生物合成脂质修饰的人单链抗体片段作为免疫脂质体的靶向分子。

Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes.

作者信息

de Kruif J, Storm G, van Bloois L, Logtenberg T

机构信息

Department of Immunology, Utrecht University, The Netherlands.

出版信息

FEBS Lett. 1996 Dec 16;399(3):232-6. doi: 10.1016/s0014-5793(96)01335-x.

DOI:10.1016/s0014-5793(96)01335-x
PMID:8985152
Abstract

A human anti-CD22 single chain (sc) Fv antibody fragment from a synthetic phage antibody display library was biosynthetically lipid-tagged by using Escherichia coli lipoprotein sequences. The purified anti-CD22 scFv lipoprotein was incorporated into liposomes by detergent dilution. Anti-CD22 immunoliposomes were shown to bind specifically in a dose- and time-dependent manner to CD22+ cell lines and CD22+ B-lymphocytes present in freshly isolated samples of blood mononuclear cells. The immunoliposomes were demonstrated to accumulate in intracellular compartments. Biosynthetically lipid-tagged human scFv antibody fragments isolated from phage display libraries may facilitate the construction of immunoliposomes with improved properties.

摘要

利用大肠杆菌脂蛋白序列对来自合成噬菌体抗体展示文库的人抗CD22单链(sc)Fv抗体片段进行生物合成脂质标记。通过去污剂稀释将纯化的抗CD22 scFv脂蛋白掺入脂质体中。结果表明,抗CD22免疫脂质体以剂量和时间依赖性方式特异性结合于新鲜分离的血液单核细胞样品中存在的CD22+细胞系和CD22+B淋巴细胞。已证实免疫脂质体在细胞内区室中积累。从噬菌体展示文库中分离的生物合成脂质标记的人scFv抗体片段可能有助于构建具有更好性能的免疫脂质体。

相似文献

1
Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes.来自噬菌体展示文库的生物合成脂质修饰的人单链抗体片段作为免疫脂质体的靶向分子。
FEBS Lett. 1996 Dec 16;399(3):232-6. doi: 10.1016/s0014-5793(96)01335-x.
2
Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin's lymphoma.用于靶向非霍奇金淋巴瘤的高稳定性内化抗CD22单链Fv片段的生成。
Int J Cancer. 2003 Dec 10;107(5):822-9. doi: 10.1002/ijc.11451.
3
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.通过抗体噬菌体展示获得的突变抗CD22免疫毒素对细胞系和新鲜白血病细胞的细胞毒性活性增强。
Clin Cancer Res. 2002 Apr;8(4):995-1002.
4
Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment.从噬菌体展示文库中筛选的人抗体框架的特异性嫁接:产生高度稳定的人源化抗CD22单链Fv片段。
Protein Eng. 2003 Oct;16(10):753-9. doi: 10.1093/protein/gzg096.
5
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.一种新型的人CD22特异性抑制剂化合物表明,CD22的配体结合结构域对于抑制B细胞受体信号是必需的。
J Exp Med. 2002 May 6;195(9):1207-13. doi: 10.1084/jem.20011783.
6
Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.鉴定CD22的配体结合结构域,CD22是免疫球蛋白超家族的一员,能独特地结合一种唾液酸依赖性配体。
J Exp Med. 1995 Apr 1;181(4):1581-6. doi: 10.1084/jem.181.4.1581.
7
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.靶向种系热点的体外抗体进化以提高抗CD22免疫毒素的活性
J Biol Chem. 2005 Jan 7;280(1):607-17. doi: 10.1074/jbc.M409783200. Epub 2004 Oct 18.
8
CD22 on the human basophils bind differently to anti-CD22 of different manufacturers.
Cytometry. 2000 Jul 1;40(3):251. doi: 10.1002/1097-0320(20000701)40:3<251::aid-cyto11>3.0.co;2-d.
9
Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).使用针对人内皮糖蛋白(CD105)的单链Fv片段将免疫脂质体靶向内皮细胞。
Biochim Biophys Acta. 2004 May 27;1663(1-2):158-66. doi: 10.1016/j.bbamem.2004.03.007.
10
A dimeric angiogenin immunofusion protein mediates selective toxicity toward CD22+ tumor cells.一种二聚体血管生成素免疫融合蛋白介导对CD22 +肿瘤细胞的选择性毒性。
J Immunother. 2005 May-Jun;28(3):245-51. doi: 10.1097/01.cji.0000161396.96582.10.

引用本文的文献

1
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes.向白细胞中特异性递呈表达治疗性蛋白的修饰 mRNA。
Nat Commun. 2018 Oct 29;9(1):4493. doi: 10.1038/s41467-018-06936-1.
2
Ligand-targeted theranostic nanomedicines against cancer.用于癌症治疗的配体靶向诊疗纳米药物。
J Control Release. 2016 Oct 28;240:267-286. doi: 10.1016/j.jconrel.2016.01.002. Epub 2016 Jan 6.
3
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv.新型 CD22-scFv 偶联脂质纳米粒对 B 细胞的特异性靶向
Exp Mol Pathol. 2010 Apr;88(2):238-49. doi: 10.1016/j.yexmp.2010.01.006. Epub 2010 Feb 1.
4
Activated vitronectin as a target for anticancer therapy with human antibodies.活化的玻连蛋白作为人源抗体抗癌治疗的靶点。
Cancer Immunol Immunother. 2004 Sep;53(9):799-808. doi: 10.1007/s00262-004-0506-z. Epub 2004 Jun 10.
5
Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.用抗ED-B纤连蛋白单链抗体修饰的脂质体对F9畸胎瘤进行细胞毒性靶向治疗。
Br J Cancer. 2002 Jul 1;87(1):106-12. doi: 10.1038/sj.bjc.6600423.
6
Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.采用半合成文库方法获取针对格雷夫斯病促甲状腺激素受体的人单克隆自身抗体的局限性。
Clin Exp Immunol. 1999 Nov;118(2):205-12. doi: 10.1046/j.1365-2249.1999.01042.x.